Keat Theng Chow

Citation: Chow KT, Ecenarro S, “Clearing the Air(Way): Debunking Three Common Myths About Inhaled Drug Delivery”. ONdrugDelivery, Issue 180 (Nov 2025), pp 52–56. Dr Keat Theng Chow and Susana Ecenarro explore three myths surrounding inhalation as a route of administration, clearing the way for a deeper understanding of one of pharma’s most exciting areas for innovation. The economic potential of inhaled therapies is truly breathtaking – and yet somehow misunderstood.

Citation: Chow KT, “Interview: Patient Experience Versus Regulatory Compliance – Can Formulators Find a Middle Ground?”. ONdrugDelivery, Issue 173 (May/Jun 2025), pp 6–9. Dr Keat Theng Chow outlines the essential themes on Roquette’s radar regarding patient-centric drug design, upcoming regulatory changes and how drug producers can navigate both spheres to the benefit of all. Q How would you describe the current landscape when it comes to patient-centricity?

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.